<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04396132</url>
  </required_header>
  <id_info>
    <org_study_id>4</org_study_id>
    <nct_id>NCT04396132</nct_id>
  </id_info>
  <brief_title>The Effect of Head Tilt and Soft Surface on Virtual SVV in Normal Subjects</brief_title>
  <official_title>The Effect of Head Tilt and Soft Surface on Virtual SVV in Normal Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pamukkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pamukkale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The sense of gravity is one of the important input of our balance system. The utricle is the
      key structure on this subject but the contribution of the proprioceptive receptors is also
      important. The aim of this study is to measure the effect of different angles of head tilt
      and soft surface on SVV in healthy subjects with a new automated system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two different settings will be used. In the first experiment, healthy subjects will make 15,
      30, and 45-degree head tilt to the left and right side while they are standing. In every
      position, 3 measurements will be done. In the second experiment, 40 health subjects will make
      the same head maneuvers on the 20 cm thick soft surface. We will compare the effects of both
      head tilt and soft surface. All measurements will be done with a virtual SVV
      system(Interacoustics).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Visual Vertical</measure>
    <time_frame>1 month</time_frame>
    <description>The measurement of deviation angle with 15, 30 and 45-degree head tilt to the left and right side while they are standing</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Vestibular Nerve Diseases</condition>
  <arm_group>
    <arm_group_label>Virtual SVV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects will be tested by virtual SVV. The deviation angle will be measured at 15, 30 and 45-degree head tilt to the left and right side while they are standing</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Subjective Visual Vertical with Virtual SVV instrument</intervention_name>
    <description>The deviation angle will be measured with 15, 30 and 45-degree head tilt to the left and right side while they are standing</description>
    <arm_group_label>Virtual SVV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No ear disease

          -  No neurologic disease

          -  No surgery for ear, brain or musculoskeletal system

        Exclusion Criteria:

          -  Diabetes mellitus

          -  Drug use effective on central nervous system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fazıl N Ardıç, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department Of Otolaryngology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fazıl N Ardıç, MD</last_name>
    <phone>902582966000</phone>
    <phone_ext>5799</phone_ext>
    <email>fnardic@pau.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Taylan Çil, MD</last_name>
    <phone>902582966000</phone>
    <phone_ext>5729</phone_ext>
    <email>cil.taylan@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pamukkale University</name>
      <address>
        <city>Denizli</city>
        <zip>20070</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fazıl N Ardıç, MD</last_name>
      <phone>+905322218972</phone>
      <email>fnardic@pau.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 17, 2020</study_first_submitted>
  <study_first_submitted_qc>May 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>May 17, 2020</last_update_submitted>
  <last_update_submitted_qc>May 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pamukkale University</investigator_affiliation>
    <investigator_full_name>Fazıl Necdet Ardıç</investigator_full_name>
    <investigator_title>Chief of Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vestibulocochlear Nerve Diseases</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be shared from university depository</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

